100%, and I genuinely hope this will become a staple treatment for the patients and SP.
So as you know, the 10% is 2/20 for this study.
I will keep an eye out for the entire study that is pending release once treatment has been administered and analysed.
The fact they are taking the study slow is excellent news (Sounds weird), but if there is potential to cause harm, then the slow pace of this study will reduce harm which should be of the utmost importance.
- Forums
- ASX - By Stock
- Ann: Halucenex Phase II Clinical Trial Update
100%, and I genuinely hope this will become a staple treatment...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)